Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Jacobson Pharma Corporation Limited ( (HK:2633) ).
Jacobson Pharma Corporation Limited announced its annual financial results for the year ending March 31, 2025, reporting a revenue increase of 7.4% to approximately HK$1,576.9 million. The company’s profit from operations rose by 24.5% to HK$414.6 million, and profit from continuing operations increased by 43.1% to HK$300.8 million. The Board has recommended a final cash dividend of HK5.50 cents per share and a special cash dividend of HK6.00 cents per share, reflecting a strong financial performance and commitment to returning value to shareholders.
More about Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited is a pharmaceutical company incorporated in the Cayman Islands. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.
Average Trading Volume: 880,176
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.57B
For an in-depth examination of 2633 stock, go to TipRanks’ Overview page.